Effectiveness of Secondary Transnasal Surgery in GH-Secreting Pituitary Macroadenomas

Endocrine Journal

Volumn 50, Issue 5, 2003, Pages 635-642

  Kurosaki, Masamichi ^a,b,d   Luedecke, Dieter K ^b   Abe, Takumi ^c  

^a TOTTORI UNIVERSITY   (Japan)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

Acromegaly; Growth hormone; Pituitary adenoma; Recurrence; Secondary surgery

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINOLOGY; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; REMISSION; TREATMENT OUTCOME;

ADENOMA; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; REOPERATION; TREATMENT OUTCOME;

EID: 0344873268     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.635     Document Type: Article

References (33)

1. Derome PJ, Visot A, Delalande O, Jedynak CP, Dupuy M, Kujas M, Peillon F, Hattou M, Kinuta Y (1991) Pituitary adenomas: our experience with tumoral recurrence after surgery. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary Adenomas: New Trends in Basic and Clinical Research. Excerpta Medica, Amsterdam: 321-327.
2. Fahlbusch R, Honegger J, Buchfelder M (1992) Surgical management of acromegaly. Endocrinol Metab Clin North Am 21: 669-692.
3. Laws ER, Fode NC, Redmond MJ (1985) Transsphenoidal surgery following unsuccessful prior therapy: an assessment of benefits and risks in 158 patients. J Neurosurg 63: 823-829.
4. Long H, Beauregard H, Somma M, Comotis R, Serri O, Hardy J (1996) Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg 85: 239-247.
5. Roelfsema F, van Dulken H, Froelich M (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 23: 555-565.
6. von Werder K, Eversmann T, Fahlbusch R, Mueller OA, Rjosk HK (1984) Endocrine-active pituitary adenomas: long-term results of medical and surgical treatment. In: Camanni F, Mueller EE (eds) Pituitary Hyperfunction. Physiological and Clinical Aspects. Raven Press, New York: 385-406.
7. Abe T, Luedecke DK (1998) Recent results of secondary transnasal surgery for residual or recurring acromegaly. Neurosurgery 42: 1013-1022.
8. Laws ER, Thapar K (1996) Recurrent pituitary adenomas. In: Landolt AM, Vance ML, Relly PL (eds) Pituitary Adenomas. Churchill Livingstone, New York: 385-393.
9. Ahmed S, Elsheikh M, Page RCL, Adams CBT, Wass JAH (1999) Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50: 561-567.
10. Giovanelli M, Losa M, Mortini P (1996) Acromegaly: surgical results and prognosis. In: Landolt AM, Vance ML, Relly PL (eds) Pituitary Adenomas. Churchill Livingstone, New York: 333-351.
11. Hardy J, Somma M (1979) Acromegaly: surgical treatment by transsphenoidal microsurgical removal of the pituitary adenoma. In: Tindall GT, Collins WF (eds) Clinical Management of Pituitary Disorders. Raven Press, New York: 209-217.
12. Ross DA, Wilson CB (1988) Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 68: 854-867.
13. Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA (1993) Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurg 78: 205-215.
14. Luedecke DK (1995) Value of transcavemous surgery in the treatment of pituitary adenomas. Eur J Endocrinol 133: 147-148.
15. Abe T, Luedecke DK (1999) Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly. Clin Endocrinol 50: 27-35.
16. Luedecke DK, Herrmann HD, Muechler HC (1987) Intraoperative GH measurement in acromegaly. In: Luedecke DK, Tollis G (eds) Growth Hormone, Growth Factors, and Acromegaly: Progress in Endocrine Research Therapy. Raven Press, New York: 245-251.
17. Luedecke DK (1988) Longterm surgical results in acromegaly. Does the immediate postoperative growth hormone level predict the outcome? In: Landolt AM, Heitz PU, Zapf J, Girard J, Del Pozo E (eds) Advances in Pituitary Adenoma Research. Pergamon Press, Oxford, vol 69: 243-252.
18. Luedecke DK, Treige W (1982) Pressure-irrigation-suction system: technical note. Acta Neurochir (Wien) 66: 123-126.
19. Kurosaki M, Luedecke DK, Knappe UJ, Flitsch J, Saeger W (2000) The value of intraoperative cytology during transsphenoidal surgery for ACTH-secreting adenoma. Acta Neurochir (Wien) 142: 865-870.
20. Quabbe HJ (1982) Treatment of acromegaly by transsphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients. Clin Endocrinol 16: 107-119.
21. Clayton RN (1999) How many surgeons to operate on acromegalic patients? Clin Endocrinol 50: 557-559.
22. Giusta A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Weder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85: 526-529.
23. Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ (1988) Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab 66: 16-23.
24. Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM, Malarkey WB, Jackson I, Vance ML, Thomer MO, Barkan A, Frohman LA, Melmed S (1992) Octreotide treatment of acromegaly: a randomized, multicenter study. Ann Intern Med 117: 711-718.
25. Halse J, Harris AG, Kvistborg A, Kjartansson O, Hanssen E, Smiseth O, Djosland O, Haas G, Jervell J (1990) A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects. J Clin Endocrinol Metabol 70: 1254-1261.
26. Hardy J, Somma M, Vezina JL (1976) Treatment of acromegaly: radiation or surgery? In: Morley TP (ed) Current Controversies in Neurosurgery. W.B.Saunders Co, Philadelphia: 377-391.
27. Luedecke DK, Lutz BS, Niedworok G (1989) The choice of treatment after incomplete adenomectomy in acromegaly: proton-versus high voltage radiation. Acta Neurochir (Wien) 96: 32-38.
28. Nelson PB, Goodmann ML, Flickenger JC, Richardson DW, Robinson AG (1989) Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy. Neurosurgery 24: 398-400.
29. Quabbe HJ, Ploeckinger U (1989) Dose-response study and long-term effects of the somatostatin analog octreotide in patients with therapy-resistance acromegaly. J Clin Endocrinol Metab 68: 873-881.
30. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30: 557-565.
31. Vance ML (1996) Acromegaly: medical treatment. In: Landolt AM, Vance ML, Relly PL (eds) Pituitary Adenomas. Churchill Livingstone, New York: 409-415.
32. van den Berg G, van Dulken H, Frolich M, Meinders AE, Roelfsema F (1998) Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery? Clin Endocrinol 49: 45-51.
33. Ganz JC (1996) Gamma knife treatment of pituitary adenomas. In: Landolt AM, Vance ML, Relly PL (eds) Pituitary Adenomas. Churchill Livingstone, New York: 461-474.